机构:[1]Beijing Tongren Eye Center, Beijing Key Laboratory of Intraocular Tumor Diagnosis and Treatment, Beijing Ophthalmology&Visual Sciences Key Lab, Medical Artificial Intelligence Research and Verification Key Laboratory of the Ministry of Industry and Information Technology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China首都医科大学附属北京同仁医院首都医科大学附属同仁医院
第一作者机构:[1]Beijing Tongren Eye Center, Beijing Key Laboratory of Intraocular Tumor Diagnosis and Treatment, Beijing Ophthalmology&Visual Sciences Key Lab, Medical Artificial Intelligence Research and Verification Key Laboratory of the Ministry of Industry and Information Technology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
通讯作者:
通讯机构:[1]Beijing Tongren Eye Center, Beijing Key Laboratory of Intraocular Tumor Diagnosis and Treatment, Beijing Ophthalmology&Visual Sciences Key Lab, Medical Artificial Intelligence Research and Verification Key Laboratory of the Ministry of Industry and Information Technology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China[*1]St Dong Jiao Min Lane, Beijing, China, 100730
推荐引用方式(GB/T 7714):
Zhang Ruiheng,Dong Jiaoyue,Li Yitong,et al.Reply to Comment on: OCT and OCTA Features of Optic Disc Melanocytoma: PHOMS, Perfusion Deficits, and Association With Vision Loss[J].American Journal Of Ophthalmology.2025,doi:10.1016/j.ajo.2025.09.003.
APA:
Zhang Ruiheng,Dong Jiaoyue,Li Yitong,Wu Haotian,Dong Li...&Wei Wenbin.(2025).Reply to Comment on: OCT and OCTA Features of Optic Disc Melanocytoma: PHOMS, Perfusion Deficits, and Association With Vision Loss.American Journal Of Ophthalmology,,
MLA:
Zhang Ruiheng,et al."Reply to Comment on: OCT and OCTA Features of Optic Disc Melanocytoma: PHOMS, Perfusion Deficits, and Association With Vision Loss".American Journal Of Ophthalmology .(2025)